Here we describe a new flow cytometry-based analysis technique termed “NF-κB fingerprinting” and demonstrate its applicability to DLBCL cell lines, DLBCL core-needle biopsy samples, and healthy donor blood samples. This evidence concerns the gene NFKB1 and diffuse large B-cell lymphoma.